DC10607JTE-013
JTE-013 is an S1PR2 antagonist used in sphingosine-1-phosphate signaling, mitochondrial dynamics and fibrosis research.
View activity & prices6 research products
DC10607JTE-013 is an S1PR2 antagonist used in sphingosine-1-phosphate signaling, mitochondrial dynamics and fibrosis research.
View activity & prices
DC10719RGX-104 is an LXR agonist for studying myeloid-derived suppressor cells, ApoE signaling and tumor immune responses.
View activity & prices
DC10923TAK-615 is an LPA1 negative allosteric modulator for receptor signaling and fibrosis-related pathway research.
View activity & prices
DC11047MRL871 (MRL-871) is an allosteric RORγt ligand used in nuclear-receptor research. Independent work also identified PPARγ partial agonism.
View activity & prices
DC11464DO-264 (DO264) is an ABHD12 inhibitor for lysophosphatidylserine metabolism and immune-lipid signaling research.
View activity & prices
DC11530Tapinarof (Benvitimod, GSK2894512) is an AHR-modulating compound for skin inflammation and keratinocyte research.
View activity & pricesJTE-013 is an S1PR2 antagonist used in sphingosine-1-phosphate signaling, mitochondrial dynamics and fibrosis research.

RGX-104 is an LXR agonist for studying myeloid-derived suppressor cells, ApoE signaling and tumor immune responses.

TAK-615 is an LPA1 negative allosteric modulator for receptor signaling and fibrosis-related pathway research.

MRL871 (MRL-871) is an allosteric RORγt ligand used in nuclear-receptor research. Independent work also identified PPARγ partial agonism.

DO-264 (DO264) is an ABHD12 inhibitor for lysophosphatidylserine metabolism and immune-lipid signaling research.

Tapinarof (Benvitimod, GSK2894512) is an AHR-modulating compound for skin inflammation and keratinocyte research.
